A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer

Background: Current PSA-based tests used to detect prostate cancer (PCa) lack sufficient specificity, leading to significant overdetection and overtreatment. Our previous studies showed that serum fucosylated PSA (Fuc-PSA) and soluble TEK receptor tyrosine kinase (Tie-2) had the ability to predict a...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jin, Ma, Shiyong, Sokoll, Lori J., Eguez, Rodrigo V., Höti, Naseruddin, Zhang, Hui, Mohr, Phaedre, Dua, Renu, Patil, Dattatraya, May, Kristen Douglas, Williams, Sierra, Arnold, Rebecca, Sanda, Martin G., Chan, Daniel W., Zhang, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120218/
https://www.ncbi.nlm.nih.gov/pubmed/33995654
http://dx.doi.org/10.7150/thno.55676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120218/
https://www.ncbi.nlm.nih.gov/pubmed/33995654
http://dx.doi.org/10.7150/thno.55676

Ejemplares similares